Finance

Lists
300261:SHE
ABA Chemicals Corp
CNÂ¥4.48
-0.88%
(-0.040) 1D
Jul 22, 3:04:28 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300261...
Open
CNÂ¥4.45
High
CNÂ¥4.57
Low
CNÂ¥4.42
Mkt. cap
4.42B
Avg. vol.
11.98M
Volume
10.02M
52-wk high
CNÂ¥9.10
52-wk low
CNÂ¥4.27
EPS
-CNÂ¥0.22
Shares outstanding
963.31M
No. of employees
1K
Open
CNÂ¥4.45
High
CNÂ¥4.57
Low
CNÂ¥4.42
Mkt. cap
4.42B
Avg. vol.
11.98M
Volume
10.02M
52-wk high
CNÂ¥9.10
52-wk low
CNÂ¥4.27
EPS
-CNÂ¥0.22
Shares outstanding
963.31M
No. of employees
1K
News stories
From sources across the web
Profile
ABA Chemicals, also known as Abachem, is a Chinese chemical manufacturing company headquartered in Taicang. The company was founded in 2006 as Suzhou ABA Chemicals, and is traded on the Shenzhen Stock Exchange as 300261. The company provides contract development and manufacturing services to the pharmaceutical, biotechnological, and agrochemical industries. It offers various services for the production of fine chemicals; intermediates; and active pharmaceutical ingredients. The company also provides unnatural amino acids, pyrazoles, triazoles, and azaindoles, as well as producing an intermediate of API Levetiracetam for the treatment of epilepsy. The company is also involved in pesticide manufacturing intermediates, and acquired the Chinese firm Shanghai Puyi Chemical to consolidate its position in this market. It also acquired Amino Chemicals, a pharmaceutical API intermediate manufacturer and member of the Dipharma Group, in 2017; Amino is based on Malta and was established in 1992. ABA and Dipharma began a working partnership in the 1980s, which provided Dipharma access to the Chinese pharmaceutical market. Wikipedia
About ABA Chemicals Corp
CEO-
Employees1.2K
FoundedJan 13, 2006
Headquarters-
SectorSpeciality chemicals
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
346.01M
334.69M
310.82M
303.59M
Cost of goods sold
291.94M
248.45M
300.89M
286.91M
Cost of revenue
291.94M
248.45M
300.89M
286.91M
Research and development expenses
27.62M
29.18M
28.68M
20.19M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36.42M
48.48M
37.47M
41.02M
Operating expense
71.36M
81.42M
103.89M
62.77M
Total operating expenses
363.31M
329.87M
404.78M
349.68M
Operating income
-17.30M
4.82M
-93.96M
-46.09M
Other non operating income
-6.17M
15.52M
-16.13M
-10.85M
EBT including unusual items
364.76K
-2.79M
-177.93M
-73.15M
EBT excluding unusual items
-14.88M
-1.61M
-124.19M
-66.74M
Income tax expense
-1.79M
-3.44M
-6.13M
-14.24M
Effective tax rate
-490.84%
123.57%
3.45%
19.47%
Other operating expenses
2.92M
2.79M
-849.91K
2.71M
Net income
4.09M
1.75M
-152.59M
-57.58M
Net profit margin
1.18%
0.52%
-49.09%
-18.97%
Earnings per share
-
-
-
-
Interest and investment income
426.83K
5.04M
-
568.87K
Interest expense
-9.10M
-9.72M
-15.90M
-10.37M
Net interest expenses
-8.68M
-4.68M
-15.90M
-9.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
17.50M
38.18M
-59.20M
-11.33M
Gain or loss from assets sale
-110.13K
110.13K
-161.52K
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more